Key result
Greater hospital competition did not improve quality measure performance but correlated positively with increased Medicare costs for heart valve surgery and AMI care (P<0.001).
Why the study?
Does higher hospital competition improve quality measure performance or reduce costs in hospitals providing procedural cardiac care?
Observational (n=2,551)
Yes
Does higher hospital competition improve quality measure performance or reduce costs in hospitals providing procedural cardiac care?
Effect estimate: Partial correlation coefficient 0.40 for HVS and 0.52 for AMI
p-value: p=<0.001
Hospital competition in procedural cardiac care is associated with increased Medicare costs but does not predict better performance on publicly reported quality metrics.
Competition linked to higher costs without quality gains in AMI/valve care; leaves open whether market policies affect procedural cardiology value.
BACKGROUND: Anesthesiologists are frequently involved in efforts to meet perioperative quality metrics. The degree to which hospitals compete on publicly reported quality measures, however, is unclear. We hypothesized that hospitals in more competitive environments would be more likely to compete on quality and thus perform better on such measures. To test our hypothesis, we studied the relationship between competition and quality in hospitals providing procedural cardiac care and participating in a national quality database. METHODS: For hospitals performing heart valve surgery (HVS) and delivering acute myocardial infarction (AMI) care in the Hospital Compare database, we assessed the degree of intrahospital competition using both geographical radius and federally defined metropolitan statistical area (MSA) to determine the degree of intrahospital competition. For each hospital, we then correlated the degree of competition with quality measure performance, mortality, patient volume, and per-patient Medicare costs for both HVS and AMI. RESULTS: Six hundred fifty-three hospitals met inclusion criteria for HVS and 1898 hospitals for AMI care. We found that for both definitions of competition, hospitals facing greater competition did not demonstrate better quality measure performance for either HVS or AMI. For both diagnoses, competition by number of hospitals correlated positively with cost: partial correlation coefficients = 0.40 (0.42 for MSA) (P < 0.001) for HVS and 0.52 (0.47 for MSA) (P < 0.001) for AMI. CONCLUSIONS: An analysis of the Hospital Compare database found that competition among hospitals correlated overall with increased Medicare costs but did not predict better scores on publicly reported quality metrics. Our results suggest that hospitals do not compete meaningfully on publicly reported quality metrics or costs.
No takes yet. Share an insight, caveat, or question.
Glick et al. (2014) conducted an observational in Heart valve surgery and acute myocardial infarction (n=2,551). Hospital competition vs. Lower hospital competition was evaluated on Quality measure performance and per-patient Medicare costs (Partial correlation coefficient 0.40 for HVS and 0.52 for AMI, p=<0.001). Greater hospital competition did not improve quality measure performance but correlated positively with increased Medicare costs for heart valve surgery and AMI care (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: